Solid Lipid Nanoparticles of Atovaquone Based on 24 Full-factorial Design

Authors

  • Noratiqah Mohtar School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Pulau Pinang, Malaysia.
  • Nurzalina Khan School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Pulau Pinang, Malaysia.
  • Yusrida Darwis School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Pulau Pinang, Malaysia.
Abstract:

Solid lipid nanoparticles of atovaquone (ATQ-SLN) were prepared by high shearhomogenization method using tripalmitin, trilaurin, and Compritol 888 ATO as the lipidmatrices and Phospholipon 90H, Tween 80, and poloxamer 188 as the surfactants. Optimizationof the formulations was conducted using 6 sets of 24 full-factorial design based on fourindependent variables that were the number of homogenizing cycles, concentration of the lipid,concentration of the co-surfactant, and concentration of the main surfactant. The dependentvariables were particle size and polydispersity index (PdI). The homogenizing cycles showed anegative influence on the dependent variables which reduced both the particle size and the PdIvalue. Moreover, a combination of certain percentages of the main surfactant and co-surfactantalso showed a negative influence that reduced both the particle size and PdI value. Selectedformulations from each design were further characterized for the entrapment efficiency andyield. The optimised formulation of ATQ-SLN consisted of trilaurin, Phospholipon 90H andTween 80 with a particle size of 89.4 ± 0.2 nm and entrapment efficiency of 83.0 ± 1.7%. Thein-vitro release evaluation of the formulation showed a complete and immediate release of ATQfrom the SLN that could be a solution to improve the poor aqueous solubility and hence poorbioavailability of the drug.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

solid lipid nanoparticles of atovaquone based on 24 full-factorial design

solid lipid nanoparticles of atovaquone (atq-sln) were prepared by high shearhomogenization method using tripalmitin, trilaurin, and compritol 888 ato as the lipidmatrices and phospholipon 90h, tween 80, and poloxamer 188 as the surfactants. optimizationof the formulations was conducted using 6 sets of 24 full-factorial design based on fourindependent variables that were the number of homogeniz...

full text

Solid Lipid Nanoparticles of Atovaquone Based on 24 Full-Factorial Design

Solid lipid nanoparticles of atovaquone (ATQ-SLN) were prepared by high shear homogenization method using tripalmitin, trilaurin, and Compritol 888 ATO as the lipid matrices and Phospholipon 90H, Tween 80, and poloxamer 188 as the surfactants. Optimization of the formulations was conducted using 6 sets of 2(4) full-factorial design based on four independent variables that were the number of hom...

full text

Solid Lipid Nanoparticles and Nano Lipid Carriers: as Novel Solid Lipid Based Drug Carrier

Interest in lipid based drug delivery has developed over the past decade fuelled by a better understanding of the multiple roles lipids may play in enhancing oral bioavailability. Moreover, the emergence of novel excipients with acceptable regulatory and safety profiles coupled with advances in formulation technologies have greatly improved the potential for successful lipid based formulations....

full text

Solid Lipid Nanoparticles: a Review

Solid lipid nanoparticles (SLN) are at the forefront of the rapidly developing field of nanotechnology with several potential applications in drug delivery and research. Due to their unique size dependent properties, lipid nanoparticles offer possibility to develop new therapeutics. The ability to incorporate drugs into nanocarriers offers a new prototype in drug delivery that could use for dru...

full text

Development and evaluation of orally disintegrating tablets of Pramipexole using full factorial design

Pramipexole is the mostly prescribed drug in patients with Parkinson disease. The incidence of Parkinson disease is related to aging and mostly developed in elderly people with difficulty in swallowing or dysphagia. In the current study we aimed to develop an orally fast disintegrating tablet (ODT) of pramipexole as a preferable alternative in geriatric patients. Hence, the fast disintegration ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 14  issue 4

pages  989- 1000

publication date 2015-10-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023